Existing reports showed that chemokine network could promote the invasiveness and angiogenesis of glioma cells [29]; the chemokine receptor CXCR7 contributed to glioma's invasion and angiogenesis, and its expression related to poor outcome in IDH1 mutant patients [30]. Here, ACKR3 is linked to central nervous system cancer.